Zikhethele - choose for you: evaluating choice-based antiretroviral therapy support for patients returning to HIV care after treatment interruption in South Africa

Zikhethele - 为您选择:评估对南非治疗中断后返回艾滋病毒护理的患者的基于选择的抗逆转录病毒治疗支持

基本信息

  • 批准号:
    10472733
  • 负责人:
  • 金额:
    $ 9.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-08-23 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY People living with HIV (PLH) are likely to cycle into and out of antiretroviral therapy (ART) services over time. Even after return to HIV care (RTC), PLH who have interrupted treatment remain vulnerable to attrition and poor treatment outcomes. A range of evidence-based ART support interventions exist including community- based and mobile health (mHealth) ART support interventions. The overarching goals of this proposal are to understand existing RTC practices, incorporate patient preference to refine a community-based and mHealth ART support intervention, and examine the role of choice in delivering RTC ART support. Candidate: Dr. Phillips is an HIV epidemiologist with training in quantitative research methods and experience with field research implementation in South Africa. She is applying for a five-year Fogarty Emerging Global Leader Award to obtain the additional training, mentorship and experience required to become a leading independent investigator capable of obtaining R-series funding. Mentoring: She has assembled an exceptional multidisciplinary team with extensive expertise in HIV intervention research in sub-Saharan Africa (SSA). Drs. Myer (University of Cape Town (UCT)) and Chi (University of North Carolina (UNC)) will serve as primary mentors providing complementary expertise on HIV intervention research and implementation science. Drs Maman (UNC) and Knight (UCT), co-mentors, are social scientists with expertise in qualitative and behavioral research particularly in the context of intervention design and evaluation. Dr. Thirumurthy (University of Pennsylvania: expertise in behavioral economics and measuring patient preference), Dr. Bekker (UCT: expertise in HIV care interventions and preference trials for contraceptive and HIV prevention methods), Dr. Hosseinipour (UNC: expertise in clinical, health service and implementation science with long-term adult HIV care in SSA) and Dr. Clouse (Vanderbilt University: expertise in mHealth intervention research in South Africa) will provide scientific advice in these areas. Training: Specific training in intervention design and evaluation – specifically incorporating implementation science, social and behavioral methods, and patient preference – will be achieved through intensive mentored training and formal coursework. This, combined with the experience gained through implementing my research aims, will establish Dr. Phillips’ independent research career investigating interventions to support lifelong HIV care. Research: The specific aims of this research are to: 1) characterize existing practices for providing RTC ART support and patient experience following RTC, 2) refine existing community-based and mHealth ART support interventions based on RTC patient preferences for modifiable attributes, and 3) determine the feasibility, acceptability and preliminary impact of offering a choice of ART support intervention to RTC patients. The results of this study will inform our understanding of RTC ART support including the role of patient choice. They will provide preliminary data needed to apply for an R01 to conduct a patient preference trial to rigorously examine the impact of patient choice in ART support delivery.
项目总结 艾滋病毒携带者(PLH)很可能随着时间的推移进入和退出抗逆转录病毒治疗(ART)服务。 即使在返回艾滋病毒护理(RTC)之后,中断治疗的PLH仍然容易受到磨损和 治疗效果不佳。存在一系列基于证据的艺术支持干预措施,包括社区- 基于和移动健康(MHealth)ART支持干预。这项提案的首要目标是 了解现有的RTC实践,纳入患者偏好以完善以社区为基础的mHealth ART支持干预,并检查在提供RTC ART支持方面的选择角色。候选人:Dr。 菲利普斯是一名艾滋病毒流行病学家,受过定量研究方法方面的培训,并具有现场经验 在南非的研究实施。她正在申请一名为期五年的福格蒂新兴全球领导者 获得成为领先的独立人士所需的额外培训、指导和经验的奖项 有能力获得R系列资金的调查员。指导:她已经组建了一个不同寻常的 在撒哈拉以南非洲(SSA)的艾滋病毒干预研究方面拥有广泛专业知识的多学科团队。戴维斯博士。 Myer(开普敦大学(UCT))和CHI(北卡罗来纳大学(UNC))将担任小学 提供艾滋病毒干预研究和实施科学方面的补充专业知识的导师。DRS 马曼(Maman)和奈特(Knight)是共同导师,他们都是社会科学家,在定性和行为方面都有专长 特别是在干预设计和评估的背景下进行研究。Thirumurthy博士(加州大学 宾夕法尼亚州:行为经济学和衡量患者偏好方面的专业知识),Bekker博士(UCT: 在艾滋病毒护理干预和避孕和艾滋病毒预防方法的偏好试验方面的专业知识)。 Hosseiniour(UNC:长期成人艾滋病毒的临床、卫生服务和实施科学方面的专业知识 Carein SSA)和Clouse博士(范德比尔特大学:南非移动健康干预研究的专业知识) 将在这些领域提供科学建议。培训:干预设计和评估方面的具体培训- 具体结合实施科学、社会和行为方法以及患者偏好-Will 通过强化的辅导性培训和正规的课程作业来实现。这一点,结合我的经历 通过实现我的研究目标而获得的,将为菲利普斯博士的独立研究生涯奠定基础 调查支持终生艾滋病毒护理的干预措施。研究:本研究的具体目的是:1) 描述在RTC之后提供RTC ART支持和患者体验的现有实践,2)改进 现有的基于社区的和基于RTC患者偏好的mHealth ART支持干预措施 可修改的属性,以及3)确定提供选择的可行性、可接受性和初步影响 ART支持对RTC患者的干预。本研究的结果将有助于我们对RTC的理解 艺术支持包括患者的角色选择。他们将提供申请R01所需的初步数据 进行患者偏好试验,严格检查患者选择在抗逆转录病毒治疗支持服务中的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tamsin Kate Phillips其他文献

Tamsin Kate Phillips的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tamsin Kate Phillips', 18)}}的其他基金

Zikhethele - choose for you: evaluating choice-based antiretroviral therapy support for patients returning to HIV care after treatment interruption in South Africa
Zikhethele - 为您选择:评估对南非治疗中断后返回艾滋病毒护理的患者的基于选择的抗逆转录病毒治疗支持
  • 批准号:
    10612080
  • 财政年份:
    2021
  • 资助金额:
    $ 9.68万
  • 项目类别:
Zikhethele - choose for you: evaluating choice-based antiretroviral therapy support for patients returning to HIV care after treatment interruption in South Africa
Zikhethele - 为您选择:评估对南非治疗中断后返回艾滋病毒护理的患者的基于选择的抗逆转录病毒治疗支持
  • 批准号:
    10295062
  • 财政年份:
    2021
  • 资助金额:
    $ 9.68万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了